Glaukos Reports Record Q2 Sales, Raises 2026 Outlook
ALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS) released its second-quarter financial results for the period ended June 30, 2026, demonstrating net sales of $185.6 million, an increase of 50…
FDA Approves Outlook Therapeutics’ Lytenava to Treat Wet AMD
ISELIN, N.J.—Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of Lytenava (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal diseases, has announced…
People, Innovation, Markets, Culture and Strategic Outlook: This Is the Future of Italian Eyewear
BUSINESS: International News By Staff Tuesday, July 21, 2026 11:55 AM ANFAO, the Italian…
AM Best Revises Outlook to Positive for Louisiana Workers’ Compensation Corporation
AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “a+”…
AM Best Revises Credit Rating Outlook of Nebraska’s FMNE to Stable
AM Best has revised the outlook to stable from negative for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the…
